BU-NOT-SET

CONTACT US
Cell and virus banking in OV development and manufacturing
  • Biologics
Cell and virus banking
White paper
Overcoming technical transfer challenges in virotherapy manufacturing
  • Biologics
virotherapy
Insight
Flexibility in gene therapy: Adapting to the unique gene therapy demands
  • Biologics
gene therapy
eBook
Webinar: An optimised Plasmid DNA platform
  • Biologics
Plasmid DNA
Webinar
The future of oral solid dose formulations
  • Drug substance
  • Industry trends
oral solid dose
Insight
Trends and challenges to impact the OSD space in 2024 and beyond
  • Industry trends
OSD
Insight
Shaping pharma's carbon-reduced future
  • Sustainability
Sustainability
Insight
Focus on sustainability: Saving water in Bengaluru
  • Sustainability
Clouds
Insight
Safe handling of highly potent active pharmaceutical ingredients
  • Drug product
  • Drug substance
Safe handling
Insight
Brochure
  • Corporate
Explore Recipharm's Full Service Offering
Insight
  • Drug product
Successful drug development
Insight
  • Manufacturing
How CDMOs can help reduce the risk of counterfeit medicines entering the supply chain
Insight
  • Drug product
Tackling complexity in scale-up
Insight
  • Industry trends
Navigating COVID-19 – the role of CDMOs
Insight
  • Drug product
Best pharmaceutical dosage forms
Insight
  • Analytical chemistry
Taking an innovative approach to analytical chemistry
Insight
  • Analytical chemistry
Recipharm and Oncopeptides collaborate in the development of Melflufen for the treatment of multiple myeloma
Insight
  • Drug product
Excipients for orally disintegrating products